Common questions about Smite (FAQ)
Q: What drug class is Smite in?
Permethrin, the active ingredient in Smite, belongs to a class of medicines known as synthetic pyrethroids. Regulatory sources classify this ingredient as a scabicide and pediculicide, meaning it is specifically intended for treating infestations caused by mites and lice.
Q: Is Smite a therapeutic or prophylactic drug?
Official regulatory documents primarily indicate Smite for the treatment of existing lice and scabies infestations. Prophylactic use, meaning using the medicine to prevent an infestation, is not indicated for the general population according to official labeling.
Q: Is Smite available in a generic formulation?
Yes, the active ingredient found in Smite, which is permethrin, is widely available in generic formulations that have been approved by various international regulatory bodies.
Q: Are there any known severe or rare side effects associated with Smite?
Beyond the common, local reactions, post-marketing reports for the cream formulation have included systemic side effects like headache, dizziness, fever, and nausea or vomiting. Rare occurrences of seizure have been included in post-marketing reports; however, a confirmed medical association with the treatment is not established in these reports.
Q: What percentage of people in clinical trials experienced common side effects with Smite?
Clinical trial data indicate that generally mild and transient burning or stinging occurred in about 10% of patients, and itching (pruritus) was reported by approximately 7% of patients. These figures reflect the rates observed in the initial studies for the 5% cream formulation.
Q: Does taking Smite typically cause fatigue or drowsiness?
While official post-marketing reports for the cream formulation have included nervous system effects like dizziness and headache, fatigue and drowsiness are not listed as common side effects in the main regulatory documents.
Q: Is nausea or stomach upset a common side effect when starting Smite?
Official post-marketing experience with the 5% cream has included reports of nausea and vomiting. However, these are not listed among the most common local side effects observed during the initial clinical trials.
Q: Does the risk of side effects change over time while taking Smite?
The typical local side effects are usually described as mild and temporary. Official documents indicate that itching and rash may sometimes continue for up to 2 to 4 weeks after treatment, which is often a lingering response to the infestation rather than a side effect of the medicine itself.
Q: Are there any known side effects that affect mood or mental clarity?
Regulatory post-marketing reports for the 5% cream have included reports of dizziness and headache. Other effects specifically related to mood or mental clarity are not commonly listed in the official product information.
Q: Does Smite affect vision in any way?
Official information states that contact with the eyes should be avoided because the cream formulation may cause mild irritation. The regulatory information does not typically list other effects on vision beyond this mild irritation.
Q: Does Smite interact with common over-the-counter pain relievers, herbal supplements, vitamins, or high-risk oral medicines?
Regulatory product information states that less than two percent of the applied permethrin is absorbed into the bloodstream. Because of this minimal systemic absorption, official regulatory documents state the cream formulation has no known clinically significant drug interactions with systemically administered medicines, including oral treatments such as NSAIDs, blood thinners, oral contraceptives, vitamins, or herbal supplements.
Q: How long does Smite remain detectable in the body after the last dose?
Due to the minimal amount of the dose absorbed into the body (less than 2%), the active ingredient is quickly processed. The inactive parts of the absorbed medicine are primarily excreted in the urine, with elimination generally complete after about one week.
Q: Is there a known 'washout' period if a patient stops taking Smite?
Official regulatory documents do not specify a formal 'washout' period after discontinuing Smite. The medication is topical and is known to be quickly eliminated from the body, with most of the absorbed component being gone within about one week.
Q: Are there any eligibility criteria related to body weight for using Smite?
The dosage instructions for the cream formulation specify that 30 grams is typically sufficient for an average adult to cover the entire body. However, body weight itself is not usually listed as a specific criterion that dictates a change in the product's use in the main regulatory documents.
Q: Where can I find public information about the clinical trials that supported Smite's approval?
Public information about the clinical trials that supported the approval of Smite is generally found on official government-run registries. These include platforms such as the National Institutes of Health's (NIH) ClinicalTrials.gov.
Q: Does the Smite product label contain a Black Box Warning?
The official regulatory labels for the permethrin cream formulation does not include a Black Box Warning. A Black Box Warning is the most serious type of warning mandated by the FDA.
Q: Is Smite considered a high-risk medication by regulatory bodies?
The active ingredient, permethrin, is listed on the World Health Organization's (WHO) List of Essential Medicines, a list that includes medications considered to meet the priority health care needs of a population. The drug is considered low in acute toxicity via the dermal route, consistent with its minimal absorption into the body.
Q: Why is Smite sometimes prescribed instead of older treatments for the same condition?
Official regulatory and public health overviews often refer to the active ingredient, permethrin, as a first-line treatment option for scabies and pediculosis in many regions. This classification indicates the drug is often relied upon due to its established efficacy and safety profile in treatment guidelines.
